Business Study links talc use to ovarian cancer — a potential boon for thousands suing J&J 5 mins read New research published this week lends credence to the more than 50,000 lawsuits against
Business Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S. 2 mins read Johnson & Johnson on Wednesday explained it designs to shell out $6.5 billion more than
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers 1 min read